You just read:

Halozyme Presents Stage One Efficacy And Safety Analysis Of Phase 2 Clinical Study In Metastatic Pancreatic Cancer Patients Treated With PEGPH20

News provided by

Halozyme Therapeutics, Inc.

Jun 04, 2016, 09:00 ET